Navigation Links
Proteome atlas for the tuberculosis pathogen

This news release is available in German.

Photographers know the problem all too well: with the naked eye, you can see which branch a bird is sitting on, but spotting the bird in the blur of branches through the telephoto lens for high-magnification images requires considerable skill. It is a similar story for researchers who are looking to study proteins, the active biomolecules of cells.

Olga Schubert, a doctoral student at ETH Zurich's Institute for Molecular Systems Biology, and her colleagues have now come up with a search aid. In order to help scientists to find a particular protein in the jumble of all other proteins (the proteome), they have produced a proteome atlas for the tuberculosis pathogen Mycobacterium tuberculosis, which they present in the latest issue of Cell Host & Microbe.

Like finding a needle in a haystack

Instead of a camera, scientists use a so-called mass spectrometer to measure proteins, which enables them to either record the overall image of the proteome or zoom in on particular sections to measure individual proteins precisely. However, for Selected Reaction Monitoring (SRM) close-ups with a telephoto lens researchers have to feed coordinates into the mass spectrometer so that it can find the selected protein in the tangle of thousands of other proteins.

Until now, scientists have had to determine the SRM coordinates for every single protein themselves, for instance when they want to study a specific biological process in the Mycobacterium. Schubert and her colleagues have made the search for the proverbial needle in a haystack easier by determining the coordinates for all the proteins of the tuberculosis pathogen. Using this new "reference work", scientists can now directly zoom in on the right spot on the proteome map.

97% of all tuberculosis proteins covered

In order to produce this resource, the team of researchers initially analysed the entire tuberculosis proteome. In doing so, they cut the proteins isolated from the Mycobacterium into many small pieces, so-called peptides, and measured them using the mass spectrometer. For every protein, they then singled out representative peptides that produced the clearest signal. They synthesised over 17,000 peptides in all and produced SRM measurement profiles for every individual piece of protein, thereby covering around 97 % of the roughly 4,000 tuberculosis proteins described. The key data of these profiles now serve as a guide to aid other scientists in finding every single protein of the pathogen.

With their overall analysis of the proteome, Schubert and her colleagues achieved such a high resolution that they even discovered previously unknown proteins, managing to add twenty-two new ones to the list of tuberculosis proteins. "Although the genome sequence of the mycobacterium has long been known, we haven't been able to decode the entire proteome yet," explains Schubert.

May aid new therapies and early detection

Researchers focus on the proteins of pathogens as they constitute the main target for new medication. Tuberculosis is still regarded as a dangerous disease, especially for patients with a weakened immune system, and multi-resistant strains of the bacteria that no longer respond to medication are increasingly becoming a problem. The classic search for new pharmaceutical products by combing through known substances for an antibacterial agent has not been as successful as expected. Scientists hope that basic research will produce results that might uncover new weak points for medication to attack. The tuberculosis proteome atlas could go a long way towards achieving this.

The coordinates recorded in it are so specific that tuberculosis proteins could also be traced in a complex mixture of proteins, such as in a patient blood or tissue sample. As a result, this data could also help researchers to develop better diagnostic methods to detect an infection as early as possible.

Researchers under Ruedi Aebersold, professor of molecular systems biology at ETH Zurich and the University of Zurich, have already produced a similar proteome atlas for the model organism yeast. Other organisms, especially pathogens, could follow suit and aid the development of new treatments.


Contact: Olga Schubert
ETH Zurich

Related biology technology :

1. Quadrant Engineering Plastic Products Assigns Production of Acetron® GP and Nylon 101 Hex/Square Rods to Atlas Fibre Company
2. Cancer Antibodies: Drug Target Atlas and Competitive Outlook
3. Roka Bioscience Kicks Off Atlas on Tour, a Mobile Demonstration Vehicle for the Food Safety Industry, at IAFP
4. Tuberculosis Immunotherapy Grant for Immunoxel Honibe Honey Lozenges
5. Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
6. From the mouths of monkeys: Swab technique spots tuberculosis in non-human primates
7. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
8. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
9. PathoGenetix Advances Commercialization of New RESOLUTION Microbial Genotyping System for Rapid Bacterial Serotyping and Strain Typing
10. PathoGenetix and FDA to Evaluate Bacterial Identification System for Use in FDA Public Health and Food Safety Efforts
11. Venter Institute-Led Team Recovers and Sequences Genome of Periodontal Pathogen from Biofilm in Hospital Sink using Single-Cell Genomics
Post Your Comments:
(Date:11/30/2015)... , Dec. 1, 2015  An interventional radiology technique shows ... the preliminary results of a study being presented today at ... North America (RSNA). --> ... for decades by interventional radiologists as a way to stop ... procedure as a means of treating obesity is new. ...
(Date:11/30/2015)... /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today ... to its Board of Directors to replace Dr. ... wealth of experience as co-founder of Resverlogix, with expertise in ... --> --> Dr. Wong remarked, "I am ... Zenith,s long standing expertise in epigenetics and the advanced stage ...
(Date:11/30/2015)... Florida , November 30, 2015 ... specializing in the development of innovative peptide and gene-based ... metastatic disease, today announced it will be presenting at ... on December 1, 2015 at 2.30 PM PT. Dr. ... and Strategic Advisor will be giving the presentation and ...
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... additional independent director, and the Company welcomes Neil ... in a recent anonymous internet report on NW Bio.  ... Linda Powers stated, "We agree with ...
Breaking Biology Technology:
(Date:11/19/2015)... 19, 2015  Based on its in-depth analysis of ... BIO-key with the 2015 Global Frost & Sullivan Award ... Sullivan presents this award to the company that has ... needs of the market it serves. The award recognizes ... expands on customer base demands, the overall impact it ...
(Date:11/17/2015)... -- Paris from 17 th ... Paris from 17 th until 19 th ... has invented the first combined scanner in the world which ... surface. Until now two different scanners were required: one for ... on the same surface. This innovation is an ideal ...
(Date:11/16/2015)... JOSE, Calif. , Nov 16, 2015 /PRNewswire/ ... developer of human interface solutions, today announced expansion ... Synaptics TouchView ™ touch controller and display ... architectural revolution of smartphones. These new TDDI products ... include TD4100 (HD resolution), TD4302 (WQHD resolution), and ...
Breaking Biology News(10 mins):